AquaPass
Fluid Overload Treatment Solution
StartupAquaPass is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2019. Fluid Overload Treatment Solution. AquaPass was founded by Yaacov Nitzan. Key investors include BRM Group. The company has 11-50 employees. Core technologies: Semiconductors & Electronics, Wearables.
The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageSeed
- ProductClinical Trial
- ModelB2B
- Employees11-50
- HQTel Aviv-Yafo
- Last RoundUndisclosed
- BRM Group
Yaacov NitzanFounder & CTO
1 article covered by sources including www.ynet.co.il.
What does AquaPass do?
AquaPass is an early-stage medical device startup aiming to revolutionize the treatment of fluid overload. Its noninvasive, drug-free fluid overload treatment system removes fluids directly from the interstitial compartment through the skin by controlling and enhancing the natural process of perspiration. The company’s award-winning, patented system is composed of a wearable body suit with a microclimate generator designed to create the optimal environmental conditions to induce both natural perspiration and its immediate evaporation, ensuring that the patient remains dry and free of thermal discomfort. The AquaPass system maintains a stable core temperature while enabling treatment to be optimized according to each patient’s individual physiology. This highly efficient and safe treatment can be provided in the hospital, at outpatient clinics, and at home.
Who founded AquaPass?
AquaPass was founded in 2019 by Yaacov Nitzan (Founder & CTO).
What sector is AquaPass in?
AquaPass operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Semiconductors & Electronics, Wearables. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Providers.
Where is AquaPass located?
AquaPass is based in Tel Aviv-Yafo, Israel.